StackTerminal.Health

BETA
Research compound

This compound is primarily studied in research/clinical settings & may not be widely available as a regulated over-the-counter supplement. Information is provided for educational purposes only — not as a recommendation to use. See our Safety page.

Strattera (Atomoxetine)

Strattera is a non-stimulant medication used to improve attention & impulse control in individuals with ADHD, offering benefits without the abuse potential associated with stimulant medications.

focusattentioncognitiveadhd
Evidence last reviewed: 05 Apr 2026
Supplement note
Private note on this supplement

Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.

Sign in to keep a private note on Strattera (Atomoxetine).
Biomarkers studied
Outcomes directly measured across the evidence records below
Cognitive
Focus / Attention
Evidence
4 records
ADHD symptom severity
Children and adolescents with ADHDSystematic review
PUBMEDHigh

Atomoxetine was found to be superior to placebo in reducing ADHD core symptoms.

Dose: 80 mgDuration: 12 weeks
Quality of life
People with ADHDMeta-analysis
PUBMEDModerate

Atomoxetine improved quality of life with moderate effect size compared to placebo.

Dose: 80 mg
Quality of life
People with ADHDSystematic review
PUBMEDModerate

Atomoxetine was associated with improvements in quality of life compared to placebo.

Dose: 80 mg
ADHD symptom severity
Adults with ADHDSystematic review
PUBMEDModerate

Nonstimulant medications, including atomoxetine, were efficacious in reducing ADHD core symptom severity.

Dose: 80 mg
Forms
Capsule
Commonly prescribed form for oral administration.
Tablet
Alternative form for those who prefer tablets.

Stacks containing Strattera (Atomoxetine)

Public community stacks that include this ingredient.

Explore all stacks →
No public stacks include this ingredient yet.